<DOC>
	<DOCNO>NCT02556190</DOCNO>
	<brief_summary>The emergence multidrug-resistant bacteria recently renew interest colistin . Data dose critically ill patient undergo extended dialysis miss . The aim study determine pharmacokinetics colistin extended dialysis critically ill patient provide dose guideline drug .</brief_summary>
	<brief_title>Colistin Pharmacokinetics Critically Ill Patients During Extended Dialysis</brief_title>
	<detailed_description>Due lack new antibiotic treatment critically ill patient multidrug-resistant bacteria , interest `` old '' antibiotic like colistin re-emerged . Lastly , colistin administer frequently especially case infection due Pseudomonas aeruginosa , Klebsiella pneumoniae Acinetobacter baumanii intensive care unit ( ICUs ) around world . However , dose colistin critically ill patient undergoing renal replacement therapy base scarce data . The aim study evaluate single multiple-dose pharmacokinetics colistin inactive prodrug colistin-methanesulfonate ( CMS ) critically ill patient acute kidney injury ( AKI ) undergo extend daily dialysis ( EDD ) . The investigator perform prospective clinical pharmacokinetic single- multiple-dose study medical surgical ICUs Hannover Medical School . ICU patient anuric AKI treat EDD receive i.v . colistin study day 1 ( possible ) day 5-9 treatment . A load dose 6 Mio IU colistin Ã­s administer 8 hour prior EDD session follow 3 Mio IU every 8 hour . Colistin Plasma concentration level well dialyzer clearance rate measure different time point .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>Indication colistin therapy Acute kidney injury AKIN III need renal replacement therapy participation study pregnancy know colistin allergy contraindication colistin therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>